» Articles » PMID: 35408895

The Role of Testosterone in the Elderly: What Do We Know?

Abstract

Testosterone is the most important hormone in male health. Aging is characterized by testosterone deficiency due to decreasing testosterone levels associated with low testicular production, genetic factors, adiposity, and illness. Low testosterone levels in men are associated with sexual dysfunction (low sexual desire, erectile dysfunction), reduced skeletal muscle mass and strength, decreased bone mineral density, increased cardiovascular risk and alterations of the glycometabolic profile. Testosterone replacement therapy (TRT) shows several therapeutic effects while maintaining a good safety profile in hypogonadal men. TRT restores normal levels of serum testosterone in men, increasing libido and energy level and producing beneficial effects on bone density, strength and muscle as well as yielding cardioprotective effects. Nevertheless, TRT could be contraindicated in men with untreated prostate cancer, although poor findings are reported in the literature. In addition, different potential side effects, such as polycythemia, cardiac events and obstructive sleep apnea, should be monitored. The aim of our review is to provide an updated background regarding the pros and cons of TRT, evaluating its role and its clinical applicability in different domains.

Citing Articles

Increased Oxidative and Nitrative Stress and Decreased Sex Steroid Relaxation in a Vitamin D-Deficient Hyperandrogenic Rodent Model-And a Validation of the Polycystic Ovary Syndrome Model.

Sziva R, Kollarics R, Pal E, Banyai B, Korsos-Novak A, Fontanyi Z Nutrients. 2025; 17(2).

PMID: 39861332 PMC: 11767255. DOI: 10.3390/nu17020201.


Associations of urinary caffeine metabolites with sex hormones: comparison of three statistical models.

Zhou J, Qin L Front Nutr. 2025; 11():1497483.

PMID: 39839288 PMC: 11747151. DOI: 10.3389/fnut.2024.1497483.


Improvement of Late-Onset Hypogonadism Symptoms of Fermented Extract in TM3 Leydig and TM4 Sertoli Cells.

Kwon H, Lee H, Choi J, Lim S, Kim T, Bae K Nutrients. 2024; 16(23).

PMID: 39683553 PMC: 11644623. DOI: 10.3390/nu16234159.


Perspectives on biomarkers of reproductive aging for fertility and beyond.

Wang S, Ren J, Jing Y, Qu J, Liu G Nat Aging. 2024; 4(12):1697-1710.

PMID: 39672897 DOI: 10.1038/s43587-024-00770-5.


Effects of Testosterone Replacement Therapy on Metabolic Syndrome in Male Patients-Systematic Review.

Mlynarz N, Miedziaszczyk M, Wieckowska B, Szalek E, Lacka K Int J Mol Sci. 2024; 25(22).

PMID: 39596286 PMC: 11594927. DOI: 10.3390/ijms252212221.


References
1.
Di Zazzo E, Galasso G, Giovannelli P, Di Donato M, Castoria G . Estrogens and Their Receptors in Prostate Cancer: Therapeutic Implications. Front Oncol. 2018; 8:2. PMC: 5778111. DOI: 10.3389/fonc.2018.00002. View

2.
Rastrelli G, Guaraldi F, Reismann Y, Sforza A, Isidori A, Maggi M . Testosterone Replacement Therapy for Sexual Symptoms. Sex Med Rev. 2019; 7(3):464-475. DOI: 10.1016/j.sxmr.2018.11.005. View

3.
Cauley J . Estrogen and bone health in men and women. Steroids. 2015; 99(Pt A):11-5. DOI: 10.1016/j.steroids.2014.12.010. View

4.
Kaufman J, Vermeulen A . The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev. 2005; 26(6):833-76. DOI: 10.1210/er.2004-0013. View

5.
Chen H, Ge R, Zirkin B . Leydig cells: From stem cells to aging. Mol Cell Endocrinol. 2009; 306(1-2):9-16. PMC: 2749461. DOI: 10.1016/j.mce.2009.01.023. View